Found: 27
Select item for more details and to access through your institution.
Cognitive effects, pharmacokinetics, and safety of zuranolone administered alone or with alprazolam or ethanol in healthy adults in a phase 1 trial.
- Published in:
- Journal of Psychopharmacology, 2024, v. 38, n. 12, p. 1122, doi. 10.1177/02698811241282777
- By:
- Publication type:
- Article
Efficacy of xanomeline and trospium chloride in schizophrenia: pooled results from three 5-week, randomized, double-blind, placebo-controlled, EMERGENT trials.
- Published in:
- Schizophrenia (2754-6993), 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41537-024-00525-6
- By:
- Publication type:
- Article
Efficacy of xanomeline and trospium chloride in schizophrenia: pooled results from three 5-week, randomized, double-blind, placebo-controlled, EMERGENT trials.
- Published in:
- Schizophrenia (2754-6993), 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41537-024-00525-6
- By:
- Publication type:
- Article
Randomized, Double-Blind, Multicenter, Noninferiority Study Comparing Paliperidone Palmitate 6-Month Versus the 3-Month Long-Acting Injectable in Patients With Schizophrenia.
- Published in:
- International Journal of Neuropsychopharmacology, 2022, v. 25, n. 3, p. 238, doi. 10.1093/ijnp/pyab071
- By:
- Publication type:
- Article
Efficacy and Safety of Roluperidone for the Treatment of Negative Symptoms of Schizophrenia.
- Published in:
- Schizophrenia Bulletin, 2022, v. 48, n. 3, p. 609, doi. 10.1093/schbul/sbac013
- By:
- Publication type:
- Article
THE PLACEBO CONUNDRUM: MITIGATING THE RESPONSE AT THE SITE LEVEL.
- Published in:
- Schizophrenia Bulletin, 2020, v. 46, p. S45, doi. 10.1093/schbul/sbaa031.101
- By:
- Publication type:
- Article
F27. EFFICACY OF MONTHLY EXTENDED-RELEASE RISPERIDONE INJECTIONS (RBP-7000) FOR THE TREATMENT OF SCHIZOPHRENIA: AN ANALYSIS OF INDIVIDUAL PANSS ITEMS.
- Published in:
- Schizophrenia Bulletin, 2019, v. 45, p. S264, doi. 10.1093/schbul/sbz018.439
- By:
- Publication type:
- Article
Evaluation of the Efficacy, Safety, and Tolerability of BI 409306, a Novel Phosphodiesterase 9 Inhibitor, in Cognitive Impairment in Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled, Phase II Trial.
- Published in:
- Schizophrenia Bulletin, 2019, v. 45, n. 2, p. 350, doi. 10.1093/schbul/sby049
- By:
- Publication type:
- Article
Phase 2 Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) in Negative and Cognitive Symptoms of Schizophrenia.
- Published in:
- Schizophrenia Bulletin, 2016, v. 42, n. 2, p. 335, doi. 10.1093/schbul/sbv072
- By:
- Publication type:
- Article
Efficacy and Safety of Xanomeline-Trospium Chloride in Schizophrenia: A Randomized Clinical Trial.
- Published in:
- JAMA Psychiatry, 2024, v. 81, n. 8, p. 749, doi. 10.1001/jamapsychiatry.2024.0785
- By:
- Publication type:
- Article
P2-377: A phase 2, double-blind, placebo-controlled study to evaluate the safety, tolerability, and effect on cognitive function of AL-108 after 12 weeks of intranasal administration in subjects with mild cognitive impairment
- Published in:
- 2008
- By:
- Publication type:
- Abstract
The emperor's clothes: Assessing the validity of scores on the Tennessee Self-Concept Scale (TSCS).
- Published in:
- Educational & Psychological Measurement, 1997, v. 57, n. 1, p. 150, doi. 10.1177/0013164497057001011
- By:
- Publication type:
- Article
Pharmacokinetics, Safety, and Tolerability of a 2-Month Dose Interval Regimen of the Long-Acting Injectable Antipsychotic Aripiprazole Lauroxil: Results From a 44-Week Phase I Study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Aripiprazole lauroxil 2-month formulation with 1-day initiation in patients hospitalized for an acute exacerbation of schizophrenia: exploratory efficacy and patient-reported outcomes in the randomized controlled ALPINE study.
- Published in:
- BMC Psychiatry, 2021, v. 21, n. 1, p. 1, doi. 10.1186/s12888-021-03420-x
- By:
- Publication type:
- Article
A structured interview guide for global impressions: increasing reliability and scoring accuracy for CNS trials.
- Published in:
- Annals of General Psychiatry, 2013, v. 12, n. 1, p. 2, doi. 10.1186/1744-859X-12-2
- By:
- Publication type:
- Article
Data Quality Monitoring in Clinical Trials: Has It Been Worth It? An Evaluation and Prediction of the Future by All Stakeholders.
- Published in:
- Innovations in Clinical Neuroscience, 2016, v. 13, n. 1/2, p. 27
- By:
- Publication type:
- Article
A long-term, phase 2, multicenter, randomized, open-label, comparative safety study of pomaglumetad methionil (LY2140023 monohydrate) versus atypical antipsychotic standard of care in patients with schizophrenia.
- Published in:
- BMC Psychiatry, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1471-244X-13-143
- By:
- Publication type:
- Article
Dynamic Gravimetry in Studying The Adsorption of Proteins Onto Metal Surfaces: Analysis and Limitations.
- Published in:
- Biotechnology Progress, 1985, v. 1, n. 2, p. 121, doi. 10.1002/btpr.5420010209
- By:
- Publication type:
- Article
Ethics in Contemporary Human Resources Management.
- Published in:
- Public Personnel Management, 1999, v. 28, n. 4, p. 501, doi. 10.1177/009102609902800401
- By:
- Publication type:
- Article
An Open-Label Study to Assess Monthly Risperidone Injections (180 mg) Following Switch from Daily Oral Risperidone (6 mg) in Stable Schizophrenic Patients.
- Published in:
- Clinical Drug Investigation, 2024, v. 44, n. 4, p. 251, doi. 10.1007/s40261-024-01347-1
- By:
- Publication type:
- Article
The Steady-State Comparative Bioavailability of Intramuscular Risperidone ISM and Oral Risperidone: An Open-Label, One-Sequence Study [Corrigendum].
- Published in:
- Drug Design, Development & Therapy, 2022, v. 16, p. 1791, doi. 10.2147/DDDT.S375987
- By:
- Publication type:
- Article
The Steady-State Comparative Bioavailability of Intramuscular Risperidone ISM and Oral Risperidone: An Open-Label, One-Sequence Study.
- Published in:
- Drug Design, Development & Therapy, 2021, v. 15, p. 4371, doi. 10.2147/DDDT.S332026
- By:
- Publication type:
- Article
Effects of the selective AMPA modulator NBI‐1065845 on the pharmacokinetics of midazolam or ethinyl estradiol–levonorgestrel in healthy adults.
- Published in:
- CTS: Clinical & Translational Science, 2024, v. 17, n. 5, p. 1, doi. 10.1111/cts.13791
- By:
- Publication type:
- Article
Population Pharmacokinetic Analysis to Support and Facilitate Switching from Risperidone Formulations to Rykindo in Patients with Schizophrenia.
- Published in:
- Neurology & Therapy, 2024, v. 13, n. 2, p. 355, doi. 10.1007/s40120-024-00578-w
- By:
- Publication type:
- Article
Combining Physically Based Modeling and Deep Learning for Fusing GRACE Satellite Data: Can We Learn From Mismatch?
- Published in:
- Water Resources Research, 2019, v. 55, n. 2, p. 1179, doi. 10.1029/2018WR023333
- By:
- Publication type:
- Article
Power in the Hypnotic Relationship: Therapeutic or Abusive?
- Published in:
- American Journal of Psychotherapy (Association for the Advancement of Psychotherapy), 1997, v. 51, n. 1, p. 67, doi. 10.1176/appi.psychotherapy.1997.51.1.67
- By:
- Publication type:
- Article
Usability of a novel digital medicine system in adults with schizophrenia treated with sensor-embedded tablets of aripiprazole.
- Published in:
- Neuropsychiatric Disease & Treatment, 2016, v. 12, p. 2587, doi. 10.2147/NDT.S116029
- By:
- Publication type:
- Article